ZSP-0678

N/A

Report date: 2024/10/23 14:57:54
NME

Base Information

Drug NameZSP-0678
Drug Alias NameZSP-0678
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor β agonists
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor β
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, SclerosingLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Zhongsheng Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangdong Zhongsheng Pharmaceutical Co LtdGuangdong Raynovent Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsCholangitis, SclerosingLiver Cirrhosis, Biliary
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A